Novogene Biopharma Services: Automated NGS, State-of-the-Art Single-Cell Sequencing, One-Stop-Shop CDx Solutions, and More
Date and Time: Wednesday, July 1, 2020 8:00 am (PST) / 11:00 am (EST) (PST)
Novogene, with sequencing centers in the US, China, UK and Singapore, is the largest capacity service provider in the world, with experience in working with biopharma companies in supporting Discovery and Pre-Clinical Research, Translational and Clinical Research, and Companion Diagnostics (CDx).
In this webinar, Dr. Jeff Cheng provides a comprehensive overview of the different types of services that Novogene provides to US pharma clients, including automated NGS, single-cell sequencing, CDx solutions, mass spectrometry, and more.
Jeff Cheng, PhD
Chief Scientific Officer at Novogene
Dr. Cheng received a Doctor in Philosophy in Chemical and Biomolecular Engineering from Rice University. He completed his post-doctoral research fellowship at Harvard Medical School, Edwin L. Steel Laboratory for Tumor Biology, Tumor Microenvironment, and Vascular Biology. He is the Chief Scientific Officer at Novogene, former Biomarker Science Leader at Genentech, and former Head of Scientific Liaison for Biomarker Research at Roche.